Gara Jalqabaatti › Sindroomii Sjogren
Qorannoo klinikaalii Sindroomii Sjogren Ameerikaa Keessatti hirmaatuu
Qorannoo 16 Sindroomii Sjogren f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 6
- Boston, MAQorannoo 5
- Washington, DCQorannoo 5
- Arlington, TXQorannoo 4
- Charlotte, NCQorannoo 4
- Tampa, FLQorannoo 4
- Cicero, ILQorannoo 4
- Cypress, TXQorannoo 3
- Tucson, AZQorannoo 3
- Clearwater, FLQorannoo 3
- Warren, MIQorannoo 3
- Kansas City, MOQorannoo 3
- Orlando, FLQorannoo 3
- Dallas, TXQorannoo 3
- Chicago, ILQorannoo 3
Naannoon
- ArizonaQorannoo 4
- CaliforniaQorannoo 5
- FloridaQorannoo 7
- IllinoisQorannoo 5
- MarylandQorannoo 6
- MassachusettsQorannoo 5
- MichiganQorannoo 3
- MissouriQorannoo 3
- New YorkQorannoo 3
- North CarolinaQorannoo 6
- OhioQorannoo 3
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 4
- TexasQorannoo 8
- VirginiaQorannoo 3
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07281456The Pathogenesis and Natural History of Sjogren's Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 16 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01425892Characterization of Diseases With Salivary Gland Involvement
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 4 hanga 100 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT02327884Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07621809A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07737743Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07404865Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06392711A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT07041099Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Namoota walitti qabaa jira
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07180537AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06991114A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Elb-2026 · NCT06747949Rheumatology Patient Registry and Biorepository
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT04402086Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Dubartoota · Haaromfame 08-Ama-2026 · NCT03276923The Myelin Disorders Biorepository Project
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 23-Onk-2025 · NCT03047369Rheumatology Diet Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT06339957Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.